The present invention provides a biomedical degradable metal capable of treating rheumatoid arthritis. The biomedical degradable metal is a magnesium alloy and contains magnesium and a second component, wherein the second component is one or a plurality of materials selected from zinc, manganese, selenium, strontium and calcium, the content of the second component is less than or equal to 10 wt%, and the balance is magnesium. According to the present invention, the magnesium alloy has characteristics of good biocompatibility, satisfactory corrosion resistance and no significant cytotoxicity, can be degraded and absorbed in biological body fluids or bloods, has application values in medical fields of endovascular interventional therapy, endosseous implant and the like, and especially releases beneficial elements through in vivo degradation so as to inhibit activation of macrophages and other inflammatory cells, promote osteoblast bone formation, and inhibit osteoclast bone resorption, such that the biomedical degradable metal has the potential effects of rheumatoid arthritis treating and the like.